Cargando…
mTOR signaling: implications for cancer and anticancer therapy
Mounting evidence links deregulated protein synthesis to tumorigenesis via the translation initiation factor complex eIF4F. Components of this complex are often overexpressed in a large number of cancers and promote malignant transformation in experimental systems. mTOR affects the activity of the e...
Autores principales: | Petroulakis, E, Mamane, Y, Le Bacquer, O, Shahbazian, D, Sonenberg, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361102/ https://www.ncbi.nlm.nih.gov/pubmed/16404421 http://dx.doi.org/10.1038/sj.bjc.6602902 |
Ejemplares similares
-
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
por: Mamane, Yaël, et al.
Publicado: (2007) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023) -
Current development of the second generation of mTOR inhibitors as anticancer agents
por: Zhou, Hong-Yu, et al.
Publicado: (2012)